Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JSPR | AMGN | VRTX | REGN | BMY |
| Company | Jasper Therapeutics Inc. | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 24.36 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 25.36 | 279.84 | 406.95 | 913.21 | 44.47 |
| Low | 23.87 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 23.99 | 277.40 | 402.14 | 903.48 | 44.21 |
| Change | +0.12 | +3.46 | +9.33 | +12.82 | +0.27 |
| % Change | +0.50% | +1.26% | +2.38% | +1.44% | +0.61% |
| Volume | 79,853 | 2,272,899 | 1,233,417 | 585,412 | 13,225,022 |
| 20-Day Average Volume | 69,610 | 2,203,185 | 976,356 | 465,011 | 13,922,095 |
| Previous Close | 23.87 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.95 | 269.74 | 398.95 | 909.26 | 48.22 |
| 20-Day Raw Stochastic | 40.66% | 92.25% | 55.87% | 35.45% | 6.61% |
| 20-Day Relative Strength | 51.43% | 53.63% | 48.56% | 43.65% | 29.08% |
| Weighted Alpha | +22.78 | +15.11 | +15.15 | +17.62 | -36.09 |
| Today's Opinion | 40% Buy | 16% Sell | 8% Buy | 8% Buy | 88% Sell |
| Previous Opinion | 56% Buy | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.94% since 04/24/24 | +1.96% since 04/24/24 | +0.58% since 04/24/24 | -0.05% since 04/24/24 | -9.37% since 04/24/24 |
| Low | 20.15 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 25.36 on 05/01/24 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -13.64% since 04/01/24 | -1.66% since 04/01/24 | -4.13% since 04/01/24 | -6.53% since 04/01/24 | -16.44% since 04/01/24 |
| Low | 20.15 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 30.70 on 04/08/24 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | +100.16% since 02/01/24 | -14.24% since 02/01/24 | -7.09% since 02/01/24 | -5.40% since 02/01/24 | -9.02% since 02/01/24 |
| Low | 11.25 on 02/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 31.01 on 04/01/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +256.63% since 11/01/23 | +6.71% since 11/01/23 | +9.14% since 11/01/23 | +14.51% since 11/01/23 | -13.65% since 11/01/23 |
| Low | 4.00 on 12/13/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 31.01 on 04/01/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 359,578 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 15,064 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -64,470,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -16,580,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 2.22 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.50 on 03/04/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |